Author

SPIROMICS

OpenAlex ID: A5086971128

Association of Urine Mitochondrial DNA to Outcomes in COPD in the SPIROMICS Cohort

2019 · M.C. Rice, K.T. Schiffer, et al. · 1

MUCQ: A Personalized Quantitative Mucin Index of the Lung for Prognosis, Diagnosis, and Monitoring Muco-obstructive Lung Diseases

2025 · M. Kesimer, G. Radicioni, et al. · American Journal of Respiratory and Critical Care Medicine

Protein Biomarkers Predictive of Acute Exacerbations in SPIROMICS and COPDGene

2024 · A. Oh, C. Guo, et al.

Loss of Airway Bacterial Phylogenetic Diversity in Mild to Moderate COPD Associates With Clinical and Pathobiological Markers of Disease Development

2023 · Y.J. Huang, K. Opron, et al.

Integrative Analysis of Extracellular Lipocalin-2 and the Lung Microbiome in Smoking and COPD

2023 · C. Healy, C. Campbell, et al.

Distinct Blood Biomarkers Associate with Visual Evidence of Interstitial Lung Abnormality on HRCT in Both SPIROMICS and COPDGene

2019 · W.K. O'Neal, R.K. Putman, et al.

Association of Circulating Cell-Free Mitochondrial DNA to Outcomes in COPD in the SPIROMICS Cohort

2019 · K.T. Schiffer, M.C. Rice, et al.

Impaired Mucus Hydration and Hydration Signaling Pathways in COPD

2019 · C.R. Esther, W.K. O'Neal, et al.

Extracellular Bronchoalveolar Lavage Fluid Ferritin and Risk for Exacerbation in COPD: An Analysis from the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

2019 · W. Zhang, C. Oromendia, et al.

Works count: 9

Citation count: 1

H-index: 1

I10-index: